Zagayko, A. L., Lytkin, D. V., & Maloshtan, A. V. (2018). The effect of third generation aromatase inhibitors on the several components of experimental metabolic syndrome. Medical and Clinical Chemistry, (4), 41–50. https://doi.org/10.11603/mcch.2410-681X.2017.v0.i4.8306